Implantable CBGM System
Diabetes - Continuous Glucose Monitoring
Investigational DeviceActive
Key Facts
Indication
Diabetes - Continuous Glucose Monitoring
Phase
Investigational Device
Status
Active
Company
About Glucotrack
Glucotrack is an innovator in the diabetes care space, developing a long-term implantable continuous glucose monitor (CBGM) designed to break the typical 3-year longevity barrier of current devices. The company has completed its first human clinical study and is progressing toward commercialization, targeting a solution that is less disruptive for patients and generates less environmental waste. Led by a seasoned team with deep expertise from companies like DexCom and Medtronic, Glucotrack is positioning itself to challenge the established CGM market with a differentiated, fully implantable product. The technology remains investigational and has not yet received FDA approval.
View full company profile